“…A kanamycin resistance determinant, aphA-3 was found located distal to Chromosomal: enzymatic modification of antibiotics. Integron-mediated resistance [113,175] Kanamycin Majority plasmid-borne, remainder chromosomal; resistance through enzymatic modification of kanamycin [140] Chloramphenicol Plasmid-borne, resistance through modification of the target site (ribosome) or alteration of the antibiotic [186] Ciprofloxacin Chromosomal: modification of gyrA and parC confers resistance [3,4,16] Erythromycin Chromosomally mediated, resistance through modification of the target site (ribosome) [166] β-Lactams Chromosomal; three mechanisms, decreased uptake through modification of a porin, alteration of a penicillin binding protein, or production of a β-lactamase [129] Tetracycline tetO gene, plasmid-borne in the majority of cases, resistance mediated through ribosomal protection [7,78,167] Trimethoprim dfr1 gene, chromosomal, located to the remnants of an integron dfr9 gene, chromosomal, located to the remnants of a transposon Resistance arising through modification of the trimethoprim target [53] Multidrug-resistance (MDR)…”